.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Andreas Huhmer

San Carlos, CA / US

Nautilus Biotechniology

Speaker

Mon, Oct 21
17:07 – 17:19 10 Min. 2 Min.
Oral presentation
OP-32
Quantitative assessment of Tau proteoform changes in iPSC-derived neurons during differentiation
New Technology: Non MS-based Proteomics
Wed, Oct 23
Poster presentation
P-III-0751
Single-molecule proteoform analysis of EGFR in cancer cells in response to therapeutic drug treatment
New Technology: Non MS-based Proteomics

Further involvements

Mon, Oct 21
17:07 – 17:19 10 Min. 2 Min.
Oral presentation
OP-29
Sensitivity and dynamic range of massively parallel single-molecule protein quantitation using protein identification by short-epitope mapping (PrISM)
New Technology: Non MS-based Proteomics
Mon, Oct 21
17:07 – 17:19 10 Min. 2 Min.
Oral presentation
OP-32
Quantitative assessment of Tau proteoform changes in iPSC-derived neurons during differentiation
New Technology: Non MS-based Proteomics
Wed, Oct 23
Poster presentation
P-III-0751
Single-molecule proteoform analysis of EGFR in cancer cells in response to therapeutic drug treatment
New Technology: Non MS-based Proteomics